Stock HOLX HOLOGIC, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Hologic, Inc.

Equities

HOLX

US4364401012

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
73.81 USD +1.69% Intraday chart for Hologic, Inc. +0.01% +3.30%
May. 29 Transcript : Hologic, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-29-2024 10:00 AM
May. 22 FDA classifies recall of Hologic's implant as 'most serious' RE

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
FDA classifies recall of Hologic's implant as 'most serious'
RE
FDA classifies recall of Hologic's implants for soft tissue as 'most serious'
RE
Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6%
MT
Hologic Fiscal Q2 Earnings, Revenue Decline; Q3 Outlook Issued, Fiscal 2024 Estimates Revised -- Shares Up After Hours
MT
Earnings Flash (HOLX) HOLOGIC Posts Q2 EPS $1.03, vs. Street Est of $0.98
MT
Earnings Flash (HOLX) HOLOGIC Reports Q2 Revenue $1.02B, vs. Street Est of $1B
MT
(HOLX) HOLOGIC Expects Fiscal Year 2024 EPS Range $4.02 - $4.12
MT
(HOLX) HOLOGIC Sees Q3 EPS Range $0.98 - $1.05
MT
Hologic, Inc. Revises Earnings Guidance for the Fiscal Year 2024
CI
Hologic, Inc. Provides Earnings Guidance for the Third Quarter of Fiscal 2024
CI
Hologic, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 30, 2024
CI
Molten Ventures portfolio firm gets bought by Hologic
AN
Molten Ventures portfolio firm to buy Endomagnetics for USD310 million
AN
Hologic to Acquire Breast Cancer Surgery Technology Firm Endomagnetics For $310 Million
MT
Hologic, Inc. signed a definitive agreement to acquire Endomagnetics Ltd. for approximately $310 million.
CI
Bayer and Hologic Collaborates to Deliver Contrast-Enhanced Mammography
CI
Hologic, Inc. and Biotheranostics, Inc. Announces Newly Published Study Results Reveal That Use of the Breast Cancer Index®? Test
CI
FDA warns of potential risk from Hologic's devices implanted in soft tissue
RE
FDA warns of potential risk of complications with use of Hologic's devices
RE
Tranche Update on Hologic, Inc.'s Equity Buyback Plan announced on September 23, 2022.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HOLX Stock
  4. News Hologic, Inc.
  5. Highlights